Beyond hazard ratios, investigators used restricted mean survival time (RMST) analysis to compare survival gains across trialed ICI combinations for mRCC.

Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

Testosterone replacement therapy (TRT) in men with secondary hypogonadism due to nonfunctioning pituitary adenomas or prolactinomas is associated with a significantly lower risk of major adverse ...

Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

Five diabetes subgroups possess specific comorbidity risk profiles, with SIRD and SIDD generally exhibiting the highest risks for kidney disease, myocardial infarction, and total mortality compared ...

Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.